Log in to save to my catalogue

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9410311

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

About this item

Full title

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

Publisher

Basel: MDPI AG

Journal title

Journal of personalized medicine, 2022-07, Vol.12 (8), p.1265

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Precision medicine refers to a highly individualized and personalized approach to patient care. Pharmacogenomics is the study of how an individual’s genomic profile affects their drug response, enabling stable and effective drug selection, minimizing side effects, and maximizing therapeutic efficacy. Rheumatoid arthritis (RA) is an autoimmune disea...

Alternative Titles

Full title

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9410311

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9410311

Other Identifiers

ISSN

2075-4426

E-ISSN

2075-4426

DOI

10.3390/jpm12081265

How to access this item